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Human trials for the treatment of cystic fibrosis lung disease with adenoviral vectors have been compli-
cated by acute inflammatory reactions of unknown etiology. Because replicating respiratory viruses can
potentiate tachykinin-mediated neurogenic inflammatory responses in airways, we studied whether the
endotracheal administration of a replication-deficient adenoviral vector potentiated this response. The vec-
tor Ad5CMVLacZ was administered endotracheally to rats and the leakage of Evans blue dye was used
to measure the capsaicin-induced neurogenic albumin extravasation. These studies show that neurogenic
albumin extravasation is significantly potentiated in the airways of rats after administration of Ad5CMV-
LacZ. This inflammatory response can be blocked by selective antagonists of the substance Preceptor
or by glucocorticoids. Therefore, (1) the acute airway inflammation observed in patients after exposure
to adenoviral vectors may exhibit a neurogenic component, which can be blocked pharmacologically, and
(2) preclinical adenoviral vector safety studies of other organs innervated by the tachykinin system, e.g.,
coronary arteries and gastrointestinal tract, should include assessment of neurogenic inflammation.
Piedimonte, G., R. J. Pickles, J. R. Lehmann, D. McCarty, D. L. Costa, and R. C. Boucher. 1997.
Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflamma-
tion. Am. J. Respir. Cell Mol. BioI. 16:250-58.
Nonreplicating adenoviral vectors have been used in a large
majority of studies designed to transfer functional cystic
fibrosis transmembrane conductance regulator (CFTR) to
the airway epithelium of cystic fibrosis (CF) patients.
Preclinical in vitro studies have revealed efficacy without
significant cellular toxicity. However, several studies suggest
that the vectors used in the initial human trials in vivo retain
significant inflammatory properties of the wild-type virus
despite their inability to replicate efficiently.
A recent double-blind vehicle controlled trial of gene
transfer in the nasal epithelium of patients with CF reported
the acute onset of local mucosal toxicity and increased albu-
min flux in the nasal lavages of 2 of 3 patients given topical
administration of a high titer of an adenoviral vector (1). Sur-
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prisingly, this inflammatory reaction was not associated with
leukocyte chemotaxis or with the release of cytokines. Al-
though none of the extensive preclinical studies had focused
on the potential for neurogenic-mediated inflammation as
being a potential problem with adenoviral vector administra-
tion, the timing and characteristics of the vector-induced
reactions observed in the human trial were compatible with
this type of response, which is caused by the local release
of substance P (SP) and other peptide neurotransmitters with
proinflammatory properties from unmyelinated sensory
nerves (2). These peptidergic nerves are widely distributed
in organs throughout the body, including the heart (3), the
gastrointestinal tract (4), and the respiratory system (2), and
their inflammatory effectscan be potentiated by a number of
agents, including viruses (5). Therefore, we hypothesized
that the sensory nerves in the respiratory mucosa are
"primed" by adenoviral vectors and may evoke exaggerated
inflammatory responses upon stimulation. If so, the acute
inflammatory reactions observed in clinical trials using
adenoviral vectors may be mediated, at least in part, by the
inflammatory neuropeptides contained in the sensory nerve
terminals.
To test this hypothesis, we used a rat model of neurogenic
inflammation. Rat tracheas were exposed in vivo to an
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adenoviral vector (Ad5CMVLacZ) similar to that used in
clinical trials and stimulated with an intravenous infusion of
capsaicin, a drug known to release SP and other peptides
from sensory nerves (6). Changes in airway vascular perme-
ability were measured using Evans blue dye as a tracer of al-
bumin extravasation (7). Vector-induced potentiation ofneu-
rogenic albumin extravasation was studied after inactivation
of the vector nucleic acid by heating or by ultraviolet (UV)
light irradiation in the presence of psoralen (8). The specific
role of the SP receptors (also known as neurokinin [NK,l
receptors) (9) was explored with exogenous administrations
of SP and with the selective receptor antagonist CP-99,994
(10). Finally the anti-inflammatory effect of steroids in this
system was assessed by treating rats with dexamethasone or
with its vehicle.
Materials and Methods
Animals
We used adult male pathogen-free Fischer F344 rats, 12 to
14 wk of age, body weight ranging from 220 to 288 g, from
Charles River Breeding Laboratories (Raleigh, NC). To pre-
vent microbial contamination, rats were housed in groups of
2 or 3 in autoclaved plastic cages isolated by filter-tops
(Micro-Isolator System, Lab Products Inc., Maywood, NJ).
All manipulations were conducted inside a laminar flow
workbench (Stay-Clean, Lab Products, Inc.). Experimental
procedures followed in this study were approved by the Ani-
mal Care and Use Committee of the Health Effect Research
Laboratory of the U.S. Environmental Protection Agency.
Preparation of Vector Suspensions
The adenoviral vector used for these studies, Ad5CMV-
LacZ, was derived from Addi 309, a mutant strain of
adenovirus type 5 which does not express functional E3 19k
protein. The LacZ transgene, under the control of the CMV
immediate early promoter, was spliced into the left end of
the viral genome by homologous recombination, replacing
the viral El region. The generation of the adenovirus vector
utilized standard protocols for adenovirus overlapping
recombination on 293 cells. The titer of the recombinant
adenoviral stock was determined by counting X-gal-stained
293 cells. Ad5CMVLacZ used in this study was purified on
CsCI gradients and the buffer containing the vector particles
(CsCI in 25 mM Tris with 25 % glycerol, pH 7.5) was ex-
changed before each experiment by passing the vector sus-
pensions through G-50 Sephadex columns (Quick Spin,
Boehringer Mannheim, Indianapolis, IN) equilibrated in
sterile phosphate-buffered saline (PBS). The virus particle
number was calculated from the optical density of the sus-
pensions measured at 260 om wavelength.
The animals used in this study were dosed with 100 IA-L
of PBS suspensions containing 3 X 1012 vector particles
per mL (p/mL), corresponding to 1 X 10" infectious units
per mL. Serial dilutions for the dose/response curves were
performed by diluting the virus stock suspension in sterile
PBS. Dosing was always performed within 2 h of resuspend-
ing the vector in PBS to prevent significant decline in viral
titer. Control rats were dosed with sterile PBS.
Vector Inactivation
Aliquots of Ad5CMVLacZ suspended in a buffer containing
33 IA-g/IA-L of 8-methoxypsoralen were irradiated with a 365
nm UV light source for 30 min on ice to inactivate the vector
nucleic acid (8). Before administration, the UV-treated vec-
tor was filtered on G-50 Sephadex columns equilibrated with
PBS. The concentrations of viral particles and infectious
units were measured before and after UV irradiation by opti-
cal density and by X-gal staining of infected 293 cells,
respectively. The number of Ad5CMVLacZ particles re-
mained unchanged after UV irradiation, whereas titers in
293 cells decreased by approximately 4 orders of magnitude.
In separate experiments, aliquots of Ad5CMVLacZ were
heat-inactivated by incubation at 65°C for 12 h. No LacZ
gene expression could be detected after exposure of 293 cells
to heat-inactivated vector.
Vector Administration
Rats were anesthetized with sodium pentobarbital (50 mg/kg
i.p.). The vocal cords were visualized with a laryngoscope,
and the trachea carefully intubated with a 16-gauge cannula.
An 18-gauge inner cannula, connected to a tuberculin sy-
ringe, was passed through the endotracheal cannula to de-
posit the 100-IA-L inoculum over the airway mucosa between
the cricoid cartilage and the first tracheal ring. Preliminary
experiments using India ink were done to obtain cannulas of
appropriate length and assure the localization of the inocu-
lum to a confined area on the tracheal surface.
Production of Neurogenic Inflammation
Five days after dosing with vector or vehicle, the rats were
anesthetized with sodium pentobarbital. Evans blue dye (30
mg/kg i.v. over 5 s) was injected to measure the extravasation
of albumin associated with the neurogenic inflammation (7).
Immediately after the injection of the tracer, sensory nerves
were stimulated by an intravenous injection of capsaicin (75
IA-g/kg over 2 min) (6). Control rats received vehicle used to
dissolve the capsaicin (1 mL/kg i.v.) to quantitate the base-
line extravasation of the tracers in the absence of neural stim-
ulation. Ten rats received an i.v. injection of SP (l ug/kg over
20 s).
Five minutes after the injection of the tracer, the chest was
opened, a cannula inserted into the ascending aorta through
the left ventricle, and the circulation perfused for 2 min with
PBS using a syringe pump set at the rate of 50 mL/min. The
trachea and main-stem bronchi were dissected and cut into
an extrathoracic segment (from the first cartilaginous ring to
the thoracic inlet) and an intrathoracic segment (from the
thoracic inlet to the end of the main-stem bronchi). The
specimens were dissected free of connective tissue, opened
along the ventral midline, blotted, weighed, and incubated
in 1 mL of formamide (Sigma, St. Louis, MO) at 50°C for
18 h to extract the extravasated Evans blue dye.
Measurement of Albumin Extravasation
The extravasation of Evans blue-labeled albumin from the
tracheal microcirculation was quantified by measuring the
optical density of the formamide extracts at a wavelength of
620 om (11). The quantity of Evans blue dye extravasated in
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the trachea, expressed in nanograms per milligram of wet
weight, was interpolated from a standard curve of Evans blue
concentrations (0.5 to 10 {tg/mL).
(7, 13). The first injection of dexamethasone or vehicle was
given within 1 h after dosing and the last was given on the
morning of the experimental day.
LacZ Histochemistry
Five days after the administration of 3 X 1012 p/mL of
Ad5CMVLacZ or sterile PBS (n = 3 per group), rats were
killed by pentobarbital overdose and their trachea and main-
stem bronchi were dissected and rinsed in PBS. The speci-
mens were fixed in 0.5 % glutaraldehyde in PBS, then rinsed
twice for 15 min in PBS containing 1 mM MgCl, at room
temperature. ~-galactosidase activity was detected by staining
for 3 h at 37°C with a solution containing X-gal (5-bromo-4-
chloro-3-indolyl-~-D-galactopyranoside, I mg/mL), 5 mM
K3Fe(CN)6, 5 mM K,Fe(CN)6, and 1 mM MgCI,.
Drugs and Chemicals
All drugs used in this study were delivered in a volume of
1 mL per kg of body weight. Evans blue dye was dissolved
in 0.9% NaC!. Capsaicin (8-methyl-N-vanillyl-6-nonenamide;
Sigma) was dissolved in a vehicle with a final concentra-
tion of 0.75% ethanol, 0.375 % Tween 80, and 0.85% NaCI
in aqueous solution. SP (Sigma) was dissolved in distilled
water to obtain the stock solution and then diluted with
0.9% NaCI to the final concentration. CP-99,994 [(+)-
(2S-3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine] and
CP-IOO,263 [(- )-(2R-3R)-3-(2-methoxybenzylamino)-2-phe-
nylpiperidine] were dissolved in 0.9% NaC! innnediately before
Figure 1. Time dependency of the potentiation of airway neuro-
genic inflammation caused by endotracheal administration of the
adenoviral vector Ad5CMVLacZ (3 x 1012 p/mL). Capsaicin-
induced extravasation of Evans blue-labeled albumin was
significantly larger than in PBS-dosed controls 18 h afte~the ad-
ministration of vector. The difference between vector-dosed and
PBS-dosed rats increased 5 days after administration. **p < 0.01,
***p <0.001 = significantly different from PBS-dosed control rats.
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Experimental Protocols
To determine whether the endotracheal administration of an
adenoviral vector resulted in an increased neurogenic inflam-
matory response, 12 rats were dosed with 3 x 1012 p/mL
of Ad5CMVLacZ. A control group of 10 rats was dosed with
sterile PBS. Five days after dosing, capsaicin was injected
into half of the vector-dosed rats and half of the PBS-dosed
rats to stimulate the airway mucosal sensory nerves. The
other vector-dosed and PBS-dosed rats received an injection
of vehicle. To explore the time course of this inflammatory
reaction to adenoviral vectors, 4 groups of rats (n = 5 per
group) dosed with 3 X 1012 p/mL of Ad5CMVLacZ or
with sterile PBS were injected with capsaicin or its vehicle
18 h after the administration of vector or PBS. To assess the
dose dependency of this response, 4 groups of rats (n = 5
or 6 per group) were dosed with titers ranging from 3 X
10" to 3 X 1010 p/mL of Ad5CMVLacZ and injected with
capsaicin 5 days later.
Todetermine whether this effectof adenoviral vectors was
a property of the viral protein capsid of the virus or was de-
pendent upon vector gene expression, 2 groups of rats (n =
6 each) were dosed with 3 X 1012 p/mL of Ad5CMVLacZ
inactivated by heating or by exposure to UV light and psora-
len. Both groups were injected with capsaicin 5 days after
dosing.
To determine whether the potentiating mechanism of
adenoviral vectors on neurogenic inflammation was operat-
ing at a pre-synaptic or post-synaptic level, a group of
Ad5CMVLacZ-dosed rats and a group of PBS-dosed con-
trols (n = 5 each) were injected with SP 5 days after dosing.
To determine whether the inflammatory reaction associated
with the endotracheal administration of vector can be
prevented by selective antagonism of the SP(NK,) receptor,
2 groups of rats (n =·5 each) dosed 5 days earlier with 3 X
1012 p/mL of Ad5CMVLacZ were pretreated with the selec-
tive SP(NK I ) receptor antagonist CP-99,994 (4 mg/kg i.v.),
or with its inactive (2R,3R)-enantiomer CP-100,263 (4 mg/
kg i.v.) 5 min before the injection of capsaicin (10, 12).
Finally, to assess the effect of glucocorticoids on this neu-
rogenic inflammatory response, 2 groups of rats dosed with
3 X 1012 p/mL of Ad5CMVLacZ were pretreated for 5 days
with dexamethasone (0.5 mg/kg/day; n = 5) or with its vehi-
cle (l mL/kg; n = 6) given as a single daily i.p. injection
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saicin-induced Evans blue extravasation 18 h after dosing
was significantly larger than in PBS-dosed controls (Figure
1). Injection of the vehicle of capsaicin induced little extrava-
sation of Evans blue-labeled albumin in the airways of rats
dosed with either Ad5CMVLacZ or with sterile PBS. A lar-
ger difference in albumin leakage between vector-dosed rats
and controls was measured 5 days after dosing. Because this
larger difference reflected a decrease in the vehicle-asso-
ciated extravasation, we chose this time point for routine
studies. Vector-mediated potentiation of neurogenic albumin
extravasation 5 days after dosing was observed both in the
extrathoracic airway, where the inoculum was originally de-
livered, and in the intrathoracic airway including the main-
stem bronchi (Figure 2).
The adenoviral vector potentiated in a dose-dependent
fashion the increase in albumin extravasation produced by
sensory nerve stimulation with capsaicin (Figure 3). This
effect was significant after administration of a vector titer
as low as 3 x 10" p/mL. Heat inactivation and UV-psora-
len inactivation of the vector nucleic acid significantly re-
duced the potentiating effectof Ad5CMVLacZ on capsaicin-
induced neurogenic inflammation in the rat airways (Figure
4). However, the effect of capsaicin after administration of
inactivated vectors was still significantly larger than in con-
trol rats dosed with PBS (heat inactivation, P = 0.003; UV-
psoralen inactivation, P = 0.040).
The leakage of Evans blue-labeled albumin induced by in-
travenous administration of SP, the principal peptide
released from sensory nerves, was significantly increased in
rats dosed with Ad5CMVLacZ compared with controls
***
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Figure 3. Dose dependency of the potentiation of airway neuro-
genic inflammation caused by endotracheal administration of
Ad5CMVLacZ. Capsaicin-induced extravasation of Evans blue-
labeled albumin was significantly larger than in PBS-dosed controls
with vector titers as low as 3 X 106 p/mL. Thus, the threshold of
this adverse effect of adenoviral vectors precedes by several orders
of magnitude the expression of transgenes in the airway epithelium
of rodents. »P < 0.05, **p < om, ***p < 0.001 = significantly
different from PBS-dosed control rats.
Figure2. Comparison of the effectof capsaicin on albumin extrava-
sation in the extrathoracic and intrathoracic airway of rats 5 days
after a localized endotracheal administration of Ad5CMVLacZ
(3 X 1012 p/mL) or PBS. The inoculum was carefully deposited
over the airway mucosa between the cricoid cartilage and the first
tracheal ring. Significant potentiation of neurogenic albumin ex-
travasation was observed both in the extrathoracic and intrathoracic
airway segments. ***p <0.001 = significantly different from PBS-
dosed control rats.
administration. Dexamethasone sodium phosphate (American
Regent Inc. , Shirley, NY) was dissolved in a vehicle contain-
ing sodium sulfite anhydrous, I mg/mL; sodium citrate anhy-
drous, 19.4 mg/mL; and benzyl alcohol, 1% vol/vol; pH 7.4).
Statistical Analysis
Data are expressed as the mean ± standard error of the mean
(SEM). The effects of Ad5CMVLacZ and sensory nerve
stimulation on mean values of Evans blue extravasation were
analyzed by two-factor analysis of variance (14). Multiple
comparisons between means were performed with the Fisher
Protected Least Significant Difference test (15). Differences
of P < 0.05 were considered significant.
Results
In rats dosed with 3 X 1012 p/mL of Ad5CMVLacZ, cap-
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Figure 4. Effect of nucleic acid inactivation on the potentiation of
neurogenic inflammation induced by the adenoviral vector Ad5CMV
LacZ. Both heat- and UV-psoralen inactivation significantly reduced
the potentiating effect of the vector on capsaicin-induced albumin
extravasation. However, the effect of capsaicin after administration
of inactivated vector was still larger than in control rats dosed with
PBS, suggesting that the effect of adenoviral vectors on neurogenic
inflammation is caused both by the viral capsid and by expression
of vector genes. »P < 0.05, ***p < 0.001 = significantly different
from rats dosed with active Ad5CMVLacZ.
(84.1 ± 6.9 versus 53.8 ± 7.9 ng/mg; n = 5 rats per group;
P < 0.05). However, the magnitude of this potentiation was
smaller than that observed with the release of endogenous
neuropeptides by capsaicin (see Figures 1-4). The extrava-
sation of Evans blue-labeled albumin produced by capsaicin
in rats dosed with Ad5CMVLacZ was fully blocked by the
SP(NK I ) receptor antagonist CP-99,994, but not by its (2R,
3R)-enantiomer CP-100,263 (Figure 5). In addition, cap-
saicin-induced Evans blue extravasation in rats dosed with
Ad5CMVLacZ was inhibited by treatment with dexameth-
asone, but not by its vehicle (Figure 6). After treatment with
dexamethasone, capsaicin-induced extravasation in vector-
dosed rats was not different from that in PBS-dosed rats
(P > 0.05).
Histochemistry for {3-galactosidase activity in the airways
of rats dosed with 3 x 1012 p/mL of Ad5CMVLacZ 5 days
earlier (Figure 7) showed high levels of gene transfer only
in the larynx, corresponding to the area of mucosa damaged
by the tip of the endotracheal cannula used for the adminis-
tration of vector. In the rest of the airway, LacZ expression
was sparse: small, patchy areas of transduction were ob-
served in the trachea as well as in the main-stem bronchi.
No evidence of {3-galactosidase activity was found in the air-
ways of control rats dosed with PBS (not shown).
Discussion
In a recently completed double-blind vehicle-controlled
Figure 5. Effect of selective antagonism of the SP(NK I ) tachyki-
nin receptor on the potentiation of neurogenic inflammation in-
duced by the adenoviral vector Ad5CMVLacZ. The extravasation
of Evans blue-labeled albumin produced by capsaicin in rats dosed
with Ad5CMVLacZ was inhibited by CP-99,994, but not by its
(2R,3R)-enantiomer CP-100,263. Thus, the potentiation of neuro-
genic inflammation caused by the administration of Ad5CMVLacZ
involves activation of the SP(NK I ) receptor and can be prevented
by the selective antagonism of this receptor. ***p < 0.001
significantly different from rats with no pretreatment.
study of adenoviral CFTR vectors in the nasal cavity of CF
subjects (1), 2 of 3 patients receiving the highest dose of vec-
tor experienced a local mucosal inflammatory response
confined to the vector-dosed nostril. This adverse response
occurred early (within 12-24 h after dosing) and was charac-
terized by mucosal swelling, increased secretions, and albu-
min leakage. Serial nasal lavages failed to demonstrate an in-
crease in the concentration of inflammatory cytokines or
leukocyte chemotaxis; however, a greater increase in lavage
cytokines and leukocytes was observed after a mucosal bi-
opsy on the side dosed with the vector, suggesting a "prim-
ing" effect.
The timing and the characteristics of vector-mediated
inflammatory reactions appeared compatible with a neuro-
genic-mediated inflammatory response (2). Neurogenic
inflammation is evokedby the stimulation ofC-type unmyeli-
nated fibers in the respiratory mucosa, which results in the
local release of peptide neurotransmitters. The tachykinin
SP is the best known of these neuropeptides, and has been
shown in a large variety of studies to have potent pro-inflam-
matory effects in the airways. In particular, exogenously de-
livered SP is known to increase airway vascular pe\meabil-
ity, thereby causing plasma extravasation and mucosa\edema
(16). The sensory nerves of the upper (17)and lower (18) re-
spiratory tract of several species, including humans, contain
SP-immunoreactive fibers in the airway epithelium and
smooth muscle, and around blood vessels. SP-containing
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dent fashion the increase in plasma extravasation produced
by sensory nerve stimulation with capsaicin (Figure 3). This
effect is significant with a vector titer as low as 3 x 1()6 pi
mL. Because of the inefficiencyof adenoviral-mediated gene
transfer in vivo (19), the threshold dose for this adverse effect
of adenoviral vectors is several orders of magnitude below
that necessary for the expression of transgenes in the normal
airway epithelium of rodents and humans. Because the ef-
fects of neurogenic inflammation may vary among species,
it is difficult to extrapolate our data to the human airway
without specific clinical studies. However, the evidence pre-
sented in this study warrants the inclusion of measurements
of neurogenic inflammation in human protocols exploring
the safety of future gene therapy vectors.
Previousstudies in rats with wild-typemurine parainfluenza
type I (Sendai) virus revealed that viral respiratory infec-
tions strongly potentiate the increase in permeability of tra-
cheal blood vessels and the adherence of neutrophils to the
vascular endothelium produced by capsaicin-induced neuro-
genic inflammation (5, 7). This effect was observed 6 days
after the administration of virus, when the pathologic changes
due to viral replication are maximal. One of the mechanisms
responsible for this potentiation seemed to be the loss of epi-
thelial cells rich in neutral endopeptidase, a peptide-de-
grading enzyme that modulates the biological activity of SP
and other tachykinins (20). This enzymatic activity is con-
centrated in the basal layer of the respiratory epithelium and
is reduced in the airways of rodents with viral respiratory in-
fections (21-23). The data shown in the present study suggest
that the potentiation of neurogenic inflammation associated
with the presence of viral particles in the respiratory tract
is independent of their ability to replicate and cause cellular
damage. Thus, it is likely that additional mechanisms, inde-
pendent of the activity of peptide-degrading enzymes, are in-
volved in the mechanism of virus-induced potentiation of
neurogenic inflammation.
***
oo
60
Evans Blue
(ng I mg)
120
nerves have been identified in several other organs, including
the heart (3) and the gastrointestinal tract (4). Release of SP
from these nerves can be induced in experimental models by
chemical stimulation of the nerves with capsaicin (6).
Figure 6. Effect of glucocorticoids on the potentiation of neuro-
genic inflammation induced by the adenoviral vector Ad5CMV-
LacZ. The extravasation of Evans blue-labeled albumin produced by
capsaicin in rats dosed with Ad5CMVLacZ was inhibited by treat-
ment with dexamethasone, but not by its vehicle. ***p < 0.001 =
significantly different from rats with no pretreatment.
Adenoviral Vector-mediated Neurogenic Inflammation
Our data indicate that the localized endotracheal administra-
tion of a nonreplicating adenoviral gene transfer vector
potentiates neurogenic inflammation in the respiratory tract
of rats, as reflected by an abnormally large increase in vascu-
lar permeability in response to sensory nerve stimulation by
capsaicin. Airway vascular permeability is not affected by
the vector in the absence of chemical nerve stimulation. This
effect of adenoviral vectors exhibits an early onset, being de-
tectable within 18 h from vector administration (Figure 1).
A larger difference in albumin leakage between vector-dosed
rats and controls was measured 5 days after dosing, which
may reflect some mucosal damage produced by the en-
dotracheal intubation that affects vascular permeability in the
control rats at 18 h but resolves by 5 days. Although the in-
oculum was deposited over a confined area of the upper tra-
cheal mucosa, potentiation of neurogenic albumin extravasa-
tion was measured in the intrathoracic airway, including the
lower trachea and main-stem bronchi, as well as in the ex-
trathoracic airway (Figure 2). This result could be produced
by a fraction of the inoculum reaching the lower airway, or
by the activation of secondary mechanisms propagating the
inflammatory process across the airway mucosa.
The Ad5CMVLacZ vector potentiates in a dose-depen-
Mechanism of Potentiation
We sought to determine whether the potentiating effect of
Ad5CMVLacZ on neurogenic inflammation was dependent
upon the expression of vector genes, or was rather a property
of the adenoviral protein capsid. Inactivation of the vector
nucleic acid by heating or by irradiation with UV light in the
presence of psoralen significantly reduced the effect of vec-
tor particles on neurogenic inflammation (Figure 4). These
results suggest that the proinflammatory effect of the adeno-
viral vector is linked in part to the expression of vector DNA
in the respiratory epithelium. However, a significant compo-
nent of this effect can still be detected after inactivation of
the vector nucleic acid, and thus seems to be associated with
a direct toxic effect of the adenoviral capsid. Further data
describing the relative activity of different components of
adenoviral vectors require studies of the neurogenic inflam-
matory effects of purified capsid proteins (fiber, penton,
hexon) and adenoviral mutants with selective deletions ofthe
viral genome.
Adenoviral vectors can produce their effect at different
levels in the complex neurogenic inflammatory pathway (2).
The mechanism of potentiation could be pre-synaptic (e.g.,
increased neuropeptide content of nerve terminals) or could
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Figure 7. Histochemical prepa-
rations representative of the
efficiency of transduction of the
LacZ reporter gene in the airway
epithelium of rats dosed with 3 x
10'2 p/mL of Ad5CMVLacZ
5 days earlier. High levels of
transduction were observed only
in the larynx, corresponding to
the area of respiratory mucosa
damaged by the tip of the en-
dotracheal cannula used for the
administration of vector (panel
A). In the rest of the airway, the
pattern of LacZ expression was
sparse: small, patchy areas of
transduction were observed in the
trachea (panel B) as well as in the
main-stem bronchi. Scale bars:
250 JIm.
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involve one or more post-synaptic levels: decreased peptide-
degrading activity, increased density and/or affinity of speci-
fic receptors, modification in the intracellular signal trans-
duction following the ligand-receptor interaction. In our
study, the albumin leakage caused by SP (l JLg/kg i.v.), the
principal peptide released from capsaicin-sensitive sensory
nerves, wassignificantly increasedin rats dosed with Ad5CMV-
LacZ compared with controls. However, the magnitude of
this potentiation was smaller than that observed with the re-
lease of endogenous neuropeptides by capsaicin. This obser-
vation indicates that the vector exerts at least part of its effect
at the post-synaptic level. The difference between SP and
capsaicin may be due to post-synaptic potentiation of other
tachykinins, e.g., neurokinins A (NKA) and B (NKA) co-
released with SP, or to pre-synaptic modifications aftbcting
the sensory nerves. It is also possible that the concentration
of injected SP reaching the receptors is lower than that re-
leased endogenously upon stimulation of sensory nerves.
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Pharmacologic Modulation of
Vector-induced Inflammation
Three mammalian NK receptors have been cloned and their
protein sequence with 7 putative transmembrane spanning
helices typical of G protein-coupled receptors defined (24).
Each of the tachykinin peptides can act as a full agonist on
each of the 3 receptors if present at sufficiently high concen-
trations. However, SP, NKA, and NKB display preferential
affinities for NK" NK2 , and NK3 receptors, respectively
(9). In our study, selective antagonism of the SP(NK,) re-
ceptor with CP-99,994 (10, 12) abolished the effect of
Ad5CMVLacZ on airway neurogenic inflammation (Figure
5). The (2R,3R)-enantiomer CP-100,263, which shares the
same pharmacologic properties of CP-99,994 but is inactive
on the SP(NK,) receptor, did not produce inhibition,
confirming the specificity of the effect of CP-99,994.
Dexamethasone has been shown to prevent the poten-
tiation of neurogenic inflammation caused by replicating
viruses in the respiratory tract (7). The neurogenic inflam-
matory effectof Ad5CMVLacZ was also abolished by treat-
ment with a relatively lowdose of this glucocorticoid (Figure
6). Glucocorticoids can inhibit the neurogenic inflammatory
cascade at multiple levels: upregulation of peptidase activity
(13, 25), inhibition of NK, receptor mRNA transcription
(26), and decrease in the SP content of dorsal root ganglia
(27). The inhibitory effect of dexamethasone on SP-induced
extravasation in the rat airways was observed with low doses
that did not affect the extravasation induced by the nonpep-
tide inflammatory mediator platelet activating factor (13).
Thus the airway neurogenicinflammation caused byadenoviral
vectors in the respiratory tract possibly can be reduced with
low doses of systemic or inhaled glucocorticoids.
This study shows that a replication-deficient adenoviral
vector similar to those used in clinical trials of gene therapy
for CF renders the airways of rats abnormally susceptible to
neurogenic inflammation. This adverse effect of adenoviral
vectors has an early onset and requires relatively low titers.
The potentiation seems to involve both pre- and post-
synaptic levels of the neurogenic inflammatory pathway and
to be caused in part by vector gene expression and in part
by a direct toxic effect of the viral capsid. The neurogenic-
mediated extravasation of albumin involves activation of the
SP(NK,) receptor and can thus be prevented by the selec-
tive antagonism of this receptor or by the use of low-dose
glucocorticoids. The potentiation of neurogenic-mediated
airway inflammation in response to replication-deficient vi-
ral vectors may contribute to the pulmonary inflammatory
reaction to adenovirus-derived CFTR vectors observed in
humans. If so, pharmacologic modulation of this inflamma-
tory pathway, e.g., receptor antagonists or glucocorticoids,
may minimize the acute toxic effects of adenoviral vectors
and perhaps allow the safe administration of the higher titers
necessary to achieve therapeutic effects. Further testing will
be required to evaluate whether these principles will apply
to other organs innervated by C-fibers that are targets for
adenovirus-mediated gene transfer.
Acknowledgments: The authors thank Dr. John A. Lowe. III (Pfizer Central Re-
search Division) for kindly providing the NK, receptor antagonist CP-99.994
and its enantiomer CP-100.263. Some ofthe findings reported in this paper were
presented at the 9th Annual North American CF Conference and at the 1996
ALA/ATS International Conference. The research described in this article has
been reviewed by the National Health and Environmental Effects Research Labo-
ratory. U.S. Environmental Protection Agency. and approved for publication.
Approval does not signify that the contents necessarily reflect the views and the
policies of the Agency nor does mention of trade names or commercial products
constitute endorsement or recommendation for use.
References
I. Knowles. M. R., K. W. Hohneker, Z. Zhou, J. C. Olsen, T. L Noah, P.-C.
Hu, M. W. Leigh, J. Engelhardt, L. J. Edwards, K. R. Jones, M. Gross-
man, J. M. Wilson, L. G. Johnson, and R. C. Boucher. 1995. A con-
trolled study of adenoviral-vector-mediated gene transfer in the nasal epi-
thelium of patients with cystic fibrosis. N. Engl. J. Med. 333:823-831.
2. Piedimonte, G. 1995. Tachykinin peptides, receptors, and peptidases in
airway disease. Exp. Lung Res. 21:809-834.
3. Weihe, E., M. Reinecke, D. Opherk, and W. G. Forssmann. 1981. Pep-
tidergic innervation (substance P) in the human heart. J. Mol. Cell.
Cardiol. 13:331-333.
4. Costa, M., 1. B. Furness, I. J. Llewellyn-Smith, R. Murphy, J. C. Born-
stein, and J. R. Keast. 1985. Functional roles for substance P-containing
neurons in the gastrointestinal tract. In Substance P Metabolism and Bio-
logical Actions. C. C. Jordan and P. Oehme, editors. Taylor & Francis,
London. 99-119.
5. Piedimonte, G., J. A. Nadel, E. Umeno, and D. M. McDonald. 1990. Sen-
dai virus infection potentiates neurogenic inflammation in the rat trachea.
J. Appl. Physiol. 68:754-760.
6. Holzer, P. 1991. Capsaicin: cellular targets, mechanisms of action, and
selectivity for thin sensory neurons. Pharmacol. Rev. 43: 143-201.
7. Piedimonte, G., D. M. McDonald, andJ. A. Nadel. 1990. Glucocorticoids
inhibit neurogenic plasma extravasation and prevent virus-potentiated ex-
travasation in the rat trachea. J. Clin. Invest. 86: 1409-1415.
8. Cotten, M., E. Wagner, K. Zatloukal, S. Phillips, D. T. Curiel, and M. L.
Birnstiel, 1992. High-efficiency receptor-mediated delivery of small and
large 48 kilobase gene constructs using the endosome-disruption activity
of defective or chemically inactivated adenovirus particles. Proc. Natl.
Acad. Sci. USA 89:6094-6098.
9. Regoli, D., G. Drapeau, S. Dion, and R. Couture. 1988. New selective
agonists for neurokinin receptors: pharmacological tools for receptor
characterization. Trends Pharmacol. Sci. 9:290-295.
10. Mcl.ean, S., R. M. Snider, M. C. Desai, T. Rosen, D. K. Bryce, K. P.
Longo, A. W. Schmidt, andJ. Heym. 1993. CP-99,994, a nonpeptide an-
tagonist of the tachykinin NK, receptor. Regul. Pept. 46:329-331.
II. Saria, A., J. M, Lundberg, G. Skofitsch, and F. Lembeck. 1983. Vascular
protein leakage in various tissues induced by substance P, capsaicin,
bradykinin, serotonin, histamine, and by antigen challenge. Naunyn
Schmiedebergs Arch. Pharmacol. 324:212-218.
12. Piedimonte, G., C. Bertrand, P. Geppetti, R. M. Snider, M. C. Desai, and
1. A. Nadel. 1993. A new NK, receptor antagonist (CP-99,994) pre-
vents the increase in tracheal vascular permeability produced by hyper-
tonic saline. J. Pharmacol. Exp. Ther. 266:270-273.
13. Piedimonte, G., D. M. McDonald, and J. A. Nadel. 1991. Neutral en-
dopeptidase and kininase II mediate glucocorticoid inhibition of neuro-
genic inflammation in the rat trachea. J. Clin. Invest. 88:40-44.
14. Zar, J, H. 1984. Two-factor analysis of variance. In Biostatistical Analysis.
Prentice-Hall, Inc., Englewood Cliffs, New Jersey, 206-235.
15. Wallenstein, S., C. L. Zucker, and J. L. Fleiss. 1980. Some statistical
methods useful in circulation research. Ore. Res. 47: 1-9.
16. Lundberg, 1. M., and A. Saria. 1982. Capsaicin-sensitive vagal neurons
involved in control of vascular permeability in rat trachea. Acta Physiol.
Scand. J 15:521-523.
17. Baraniuk, J. N., J. D. Lundgren, J. Mullol, M. Okayama, M. Merida, and
M. Kaliner. 1991. Substance P and neurokinin A in human nasal mucosa.
Am. J. Respir. Cell Mol. Bioi. 4:228-236.
18. Lundberg, J. M., T. Hokfelt, C.-R. Martling, A. Saria, and C. Cuello.
1984. Substance P-immunoreactive sensory nerves in the lower respira-
tory tract of various mammals including man. Cell Tissue Res.
235:251-261.
19. Grubb, B. R., R. J. Pickles, H. Ye, J. R. Yankaskas, R. N. Vick, J. F.
Engelhardt, J. M. Wilson, L. G. Johnson, and R. C. Boucher. 1994.
Inefficient gene transfer by adenovirus vector to cystic fibrosis airway
epithelia of mice and humans. Nature 371:802-806.
20. Nadel, J. A. 1992. Regulation of neurogenic inflammation by neutral en-
dopeptidase. Am. Rev. Respir. Dis. 145:S48-S52.
21. Jacoby, D. B., J. Tamaoki, D. B. Borson, andJ. A. Nadel. 1988. Influenza
infection causes airway hyperresponsiveness by decreasing
enkephalinase. J. Appl. Physiol. 64:2653-2658.
22. Dusser, D., D. Jacoby, T. Djokic, I. Rubinstein, D. Borson, and J. Nadel.
1989. Virus induces airway hyperresponsiveness to tachykinins: role of
neutral endopeptidase. J. Appl. Physiol. 67:1504-1511.
 
258 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL. 161997
23. Borson, D., J. Brokaw, K. Sekizawa, D. McDonald, and 1. Nadel. 1989.
Neutral endopeptidase and neurogenic inflammation in rats with respira-
tory infections. J. Appl. Physiol. 66:2653-2658.
24. Nakanishi, S. 1991. Mammalian tachykinin receptors. Ann. Rev. Neurosci.
14:123-136.
25. Borson, D. B., and D. C. Gruenert. 1991. Glucocorticoids induce neutral
endopeptidase in transformed human tracheal epithelial cells. Am. J.
Physiol. 260(Lung Cell. Mol. Physiol. 4):L83-L89.
26. Ihara, H., and S. Nakanishi. 1990. Selective inhibition of expression of the
substance Preceptor mRNA in pancreatic acinar AR42J cells by glucocor-
ticoids. J. BioI. Chern. 265:22441-22445.
27. Smith, G. D., J. R. Seckl, W. J. Sheward, J. G. Bennie, S. M. Carrol,
H. Dick, and A. J. Harmar. 1991. Effect of adrenalectomy and dexameth-
asone on neuropeptide content of dorsal root ganglia in the rat. Brain Res.
564:27-30.
 
